skip to content

Department of Chemical Engineering and Biotechnology

 

Heikki and Dan

During 2003, Heikki Lanckriet (on the left in the photograph) and Daniel Jones (on the right) of the Department of Chemical Engineering formed Novexin and won £10,000 in the Cambridge University Entrepreneurs Business Plan Competition.

Novexin is a biotechnology company seeking to further develop and commercialise its proprietary protein processing technology. The company is addressing the need for protein purification and refolding techniques that are robust, high-yielding and easy to scale-up for industrial production.

In February 2004, they announced that Novexin has acquired technology, originating from Cambridge University, to produce proteins from DNA through a novel protein refolding process and that they have raised £400,000 in seed investment from investors including Cambridge Capital Group and business angels to further develop the process.

Latest news

'The science of small things': Ljiljana Fruk gives TEDx talk on bio-nanotechnology in medicine

12 December 2019

Watch Dr Ljiljana Fruk, head of our Bionano Engineering group, share her research into bio-nano hybrid materials for medical diagnostics, targeted drug delivery and tissue engineering at TEDx Koenigsallee in Germany.

Alumna Deborah Grubbe President-elect of AIChE

6 December 2019

Alumna and former Winston Churchill Scholar Deborah Grubbe has been named President-elect 2020 of the American Institute of Chemical Engineering (AIChE)

MBE students in highlight city event on tackling air pollution

6 December 2019

Our MPhil in Bioscience Enterprise students Adam Karlsson and Sven Hollmann on 'Tackling Toxic Air Pollution in Cities' event organised by the Centre on Global Health Security at Chatham House in London